About Aristo Pharmaceuticals
Aristo Pharmaceuticals is a company based in Mumbai (India) founded in 1971. The company has 9,848 employees as of February 17, 2025. Aristo Pharmaceuticals offers products and services including ProGG and MONOCEF.
- Headquarter Mumbai, India
- Employees 9848 as on 17 Feb, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Aristo Pharmaceuticals Private Limited
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$595.14 M (USD)12.09as on Mar 31, 2024
-
Net Profit
$171.3 M (USD)16.92as on Mar 31, 2024
-
EBITDA
$193.41 M (USD)10.41as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
9848
as on Feb 17, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aristo Pharmaceuticals
Aristo Pharmaceuticals offers a comprehensive portfolio of products and services, including ProGG and MONOCEF.
Probiotic products are offered that include the L. rhamnosus GG formulation
Antibiotic products are provided that encompass ceftriaxone-based formulations
Funding Insights of Aristo Pharmaceuticals
Detailed funding history for Aristo Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aristo Pharmaceuticals
Investment portfolio details for Aristo Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aristo Pharmaceuticals
Detailed financials for Aristo Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aristo Pharmaceuticals Comparisons
Peer comparison for Aristo Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aristo Pharmaceuticals
Detailed competitors of Aristo Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aristo Pharmaceuticals
Complete news archive for Aristo Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aristo Pharmaceuticals
Aristo Pharmaceuticals was founded in 1971.
Aristo Pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Feb 17, 2025, the latest employee count at Aristo Pharmaceuticals is 9,848.
Annual revenue of Aristo Pharmaceuticals is $595.14M as on Mar 31, 2024.
It is observed that Aristo Pharma is positioned as a key player in the Indian pharmaceutical market, holding ranks such as 3rd in its covered market and 5th in prescription audits, with revenues exceeding 5700 crores as per IQVIA data. The company has launched innovative products like ProGG, the worlds leading probiotic, and has introduced over 21 formulations first in India, spanning areas like anti-infectives and gastro intestinal therapies. Growth is demonstrated through a 10.76 CAGR over five years, supported by a sales force of 5100, while operating with seven marketing divisions to maintain a strong market presence.
Aristo Pharmaceuticals offers ProGG and MONOCEF.